Raymond James & Associates’s Eledon Pharmaceuticals ELDN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-611
| Closed | -$10K | – | 3644 |
|
2020
Q3 | $10K | Buy |
+611
| New | +$10K | ﹤0.01% | 3449 |
|
2019
Q2 | – | Sell |
-608
| Closed | -$44K | – | 3543 |
|
2019
Q1 | $44K | Hold |
608
| – | – | ﹤0.01% | 3432 |
|
2018
Q4 | $18K | Hold |
608
| – | – | ﹤0.01% | 3393 |
|
2018
Q3 | $51K | Buy |
+608
| New | +$51K | ﹤0.01% | 3438 |
|